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Abstract
Objectives: We conducted a demonstration project to assess the value of a
nurse practitioner (NP) based coronary artery disease management (CAD-DM)
program for patients with an acute coronary syndrome (ACS) or percutaneous
coronary intervention.
Methods: Patients were recruited to attend three 1-h monthly visits. The in-
tervention included assessment of clinical symptoms and guideline-based treat-
ments; education regarding CAD/ACS; review of nutrition, exercise, and ap-
propriate referrals; and recognition of significant symptoms and emergency
response.
Results: Two hundred thirteen (84.5%) completed the program. Physician ap-
proval for patient participation was 99%. Average age was 63 ± 11 years, 70%
were male, and 89% white. At baseline, 61% (n = 133) had one or more car-
diopulmonary symptoms, which declined to 30% at 12 weeks, p < .001. Sixty-
nine percent attended cardiac rehabilitation or an exercise consult. Compared to
the initial assessment, an additional 20% were at low-density lipoprotein choles-
terol < 70 mg/dL (p = .04), an additional 35% met exercise goals (p < .0001),
and there was an improvement in the mental (baseline 49.7 vs. 12 weeks 53,
p = .0015) and physical components (44 vs. 48, p = .002) of the SF-12 health
survey.
Conclusion: This NP-based CAD-DM program was well received and partici-
pants demonstrated improvement in physical and mental health, and increased
compliance with recommended lifestyle changes.
Introduction
Approximately 1.4 million hospitalizations occur annu-
ally for acute coronary syndromes (ACS), which include
ST segment myocardial infarction (STEMI), non-STEMI
(NSTEMI), and unstable angina (UA) (Roger et al., 2012).
Despite advances in treatment and the availability of
evidence-based guidelines for ACS management, there is
a treatment paradox in which higher risk patients are less
likely to receive secondary prevention measures (Motivala
et al., 2011; Smith et al., 2006). Almost 20% of ACS
patients are rehospitalized within 1 year of discharge,
accounting for 60% of the direct costs related to managing
ACS (Kolansky, 2009). Mensin et al. reported the mean
per-patient cost of care in the first year following an
ACS event, for labor age patients, was almost $23,000
per patient more than the first event itself (Kolansky,
2009; Menzin, Wygant, Hauch, Jackel, & Friedman, 2008;
Shetty, Halpern, & McCollam, 2008).
Cost-effective secondary coronary artery disease preven-
tion strategies continue to improve patient outcomes, re-
duce unnecessary healthcare expenditures, but evidence
suggests that up to 26% of opportunities to provide
guideline-recommended care are missed (Peterson et al.,
2006). Thus, disease management programs have emerged
as an avenue in which evidence-based care is provided to
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a population defined by a common illness that requires
significant self-care efforts (Clark, Hartling, Vandermeer,
& McAlister, 2005; Faxon et al., 2004; Peterson, Albert,
Amin, Patterson, & Fonarow, 2008; Turner et al., 2008).
Care provided by nurse practitioners (NPs) has a high
satisfaction rate, clinical outcomes similar to physicians,
and is cost effective (Bauer, 2010; Mattke, Seid, & Ma,
2007). NPs place a high value on prevention, emphasize
active listening, and focus education and coaching on both
their patients and families to promote self-care behaviors
(Bauer, 2010; Budzi, Lurie, Singh, & Hooker, 2010; DiMat-
teo, 2004; Watts, Gee, & O’Day, 2009).
We hypothesized that patients with ACS or post-
percutaneous coronary intervention (PCI) who at-
tended an NP-based coronary artery disease management
program (CAD-DM) postdischarge would demonstrate
improved compliance with evidence-based self-care be-
haviors for risk factor reduction, display improvement in
both physical and mental health, and express high satis-
faction with their care.
Methods
Patients who were employed by one of two local large
corporations, covered under the company-sponsored Blue
Cross-Blue Shield (BC-BS) health insurance plan, and
were discharged from a university hospital between 2001
and 2007 with a diagnosis of ACS or elective PCI were el-
igible for the CAD-DM program. Sponsorship for this pro-
gram was provided by a grant from the University Disease
Management Program that received funding from the two
corporations and BC-BS. The goal of funding was to iden-
tify diseases with a high risk for readmission and design
programs to improve care at the same or reduced cost.
After obtaining physician approval, patients were con-
tacted by a trained research assistant to determine eligi-
bility and interest in participating in the program. The
program was described to the patient as an effort on the
part of the cardiovascular care team to help the primary
care physician and cardiologist improve their care, par-
ticularly in light of the short length of hospital stay. Pa-
tients were made aware that it was entirely voluntary,
the cost would be assumed by their employer, and the
objectives of the program were to facilitate understand-
ing of the disease process, proper medication use, and
lifestyle modifications to reduce the likelihood of a future
event. At the time of the first visit, written informed con-
sent was obtained for participation and follow-up as ap-
proved by the University of Michigan Institutional Review
Board.
The goals of the program were to (a) see patients within
2 weeks of hospital discharge, (b) assess the initiation or
compliance with evidence-based secondary coronary pre-
vention treatments prescribed at discharge, and (c) assess
cardiovascular symptoms and risk factors with emphasis
on lifestyle modification. The program consisted of three
1-h visits with an experienced cardiovascular NP over a
12-week period. Patients were seen for a baseline visit with
return appointments 1 and 3 months from the initial visit.
If needed, the NP would see patients, between these visits,
for continuation of care. Every patient received individual-
ized education by the NP at each visit, based on risk factors,
knowledge deficits, and patient requests. Spouse and fam-
ily participation was highly encouraged (DiMatteo, 2004).
A summary of the program is presented in Figure 1.
At the initial visit, a comprehensive cardiovascular risk
assessment included blood pressure, heart rate, weight,
waist circumference, height, physical exam, electrocar-
diogram, fasting lipid panel, and basic metabolic pro-
file. Quality of life (QoL) was assessed using the SF-
12 Heath Survey (SF-12) (Ware, Koskinski, & Keller,
1999), depression was assessed by the Patient Health
Questionnaire (PHQ-9) questionnaire (McManus, Pipkin,
& Whooley, 2005), and coronary artery disease and coro-
nary risk factor knowledge by way of a nonvalidated
22-item questionnaire developed by the NP. Questions
centered around cardiovascular risk factors, appropriate
response to acute chest pain, lipid, blood pressure, and
exercise goals, foods low in saturated fat/cholesterol, and
impact of smoking, obesity, and diabetes to heart dis-
ease. Scoring was expressed as a percentile of correct
answers. A Likert scale of 1–10 was used to assess pa-
tient’s readiness to change in the areas of diet, exer-
cise, stress management, and smoking, which was adopted
from the modified works of Prochaska et al. (Prochaska,
DiClemente, & Norcross, 1992). At the conclusion of
each visit, patients were asked to rate (Likert scale) their
confidence to adequately manage their coronary artery
disease.
Statistical analysis
All continuous variables are presented as mean ± 1
standard deviation and categorical variables are presented
as frequencies and percentages. Paired t-tests were used
for continuous variables from baseline to the end of
the 12-week program. McNemar’s chi-square and exact
tests were used for changes in proportions of categor-
ical variables. All analyses were performed using SAS
V9.1.
Results
A total of 674 patients were screened for eligibility.
Approximately half (n = 353, 52.4%) declined partic-
ipation or did not respond, 38 (5.6%) patients were
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Figure 1 The CAD-DM process flow for patients who participated.
ineligible, and 31 (4.6%) patients agreed to participate
but did not attend the initial visit. Of the remaining
252 patients who attended the first visit, 22 (8.7%) did not
return despite NP recommendation, 13 (5%) were seen
more than once but dropped out before the third visit, 1
(0.4%) died of a cardiac event, and 3 (1.2%) had missing
data. The final analysis included the 213 patients (33.4%
of the eligible patients) who completed the program. The
mean number of days from discharge to initial visit was
36.4 ± 28.4 days (median 30 days). Patients were asked
to report their readiness to change habits in diet, exercise,
and stress management. Results at baseline and 12 weeks
indicated a motivated group with a score greater than 8 (1
= not thinking of changing and 10 = very ready to change) in
all three categories.
Baseline characteristics of the participants are described
in Table 1. Mean age was 63 ± 11 years. The study
cohort was composed of predominantly Caucasian males
who were married and well educated, and with a family
income less than $75,000. Ninety-three percent of par-
ticipants had an ACS of which 59% had UA, 19% an
NSTEMI, and 15% a STEMI, and 4% an elective PCI
(Table 2). Over 90% of those with an ACS underwent a
PCI, of which over 90% received stents. Prior to the in-
dex event, 63% of patient’s had hypertension, 30.5% had
diabetes, 55% had chronic obstructive pulmonary disease,
34% had preexisting coronary heart disease, and 36% had
previous coronary revascularization (Table 2).
The drug therapies at the initial visit and 12 weeks are
presented in Table 3. The high use of evidence-based med-
ications at initial visit reflects the discharge planning pro-
cess that required the discharging physician to document
reasons why they did not recommend guideline-based
therapies.
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Table 1 Demographics
Variable Number (%)
Age 63 ± 11.0 years
Gender
Male 149 (70)
Female 64 (30)
Ethnicity
Caucasian 190 (89.2)
African American 13 (6.1)
Other 10 (4.7)
Marital status
Married 162 (76)
Divorced 26 (12)
Single 13 (6)
Widowed 11 (5)
Education
High school 41 (19.2)
Some college/associate 75 (35.2)
Bachelor’s degree 35 (16.4)
Graduate degree 58 (27.2)
Income
Less than $50K 91 (42.7)
$50K–$74,999 37 (17.4)
$75K or more 53 (24.9)
Table 2 Clinical indication for CAD-DM and past history
Number (%)
Acute coronary syndrome % PCI
STEMIa 31 (14.5) 94%
NSTEMIa 41 (19.2) 87%
Unstable angina 126 (59.1) 92%
Elective PCI 9 (4.2)
Past history
Carotid artery disease 19 (9)
Chronic renal insufficiency 12 (6)
COPDa 117 (55)
Coronary heart disease 72 (34)
CABGa 22 (11)
Percutaneous coronary intervention 33 (19)
Both (CABG + PCI) 11 (5.5)
Diabetes 56 (30.5)
Hypertension 134 (63)
Peripheral vascular occlusive disease 9 (4)
Stroke 3 (1)
STEMI, ST segment elevation myocardial infarction; NSTEMI, non-ST seg-
ment elevation myocardial infarction; PCI, percutaneous coronary inter-
vention; COPD, chronic obstructive pulmonary disease; CABG, coronary
artery bypass grafting.
Coronary risk factors
All patients were provided education and counseling
on cardiovascular risk factors including: smoking, blood
pressure, lipids, exercise, weight, diabetes, and stress per
the American Heart Association/American College of
Cardiology (AHA/ACC) guidelines. Initial and 12-week
values for coronary risk variables are summarized in
Table 3. The number of patients not at blood pressure goal
decreased over the course of the program from 17.8% to
15.0% (p < .001). The NP referred 167 of the 213 (78%)
patients to a certified dietitian of whom 69% attended
at least one session with an average of 2.13 sessions per
patient. Referrals were made based on the NP assessment
of need and patient expressed desire to meet with a
dietician. Mean weight loss in the obese cohort (body
mass index [BMI] > 30 kg/m2) was 4.6 ± 8.2 lbs (range
13.5 lb gain to 33.0 lb loss). At baseline, 47.9% of patients
fell into the obese category, which decreased to 43.2%
at 12 weeks, p = .02. Smoking cessation was emphasized
at each visit and three of the 15 (7%) smokers quit by
12 weeks. The remaining 12 smokers who did not stop
self-reported a lack of confidence to change this behavior.
The mean lipid parameters at baseline reflected the use
of lipid lowering agents (Table 3). At the initial visit,
93% of subjects were taking statins and some were on
combined lipid-lowering therapy (5% ezetamibe, 1.9%
gemfibrozil, 3% niacin, and 1.4% fenofibrate). All thera-
pies were continued. There were significant improvements
in non-high-density lipoprotein cholesterol (non-HDL-C),
low-density lipoprotein cholesterol (LDL-C), and triglyc-
erides and a modest but nonsignificant increase in HDL-
C (p = .30). At their initial visit, 81% of patients were
at the non-HDL-C goal of <130 mg/dL, which increased
at the 12-week visit to 89%, p = .0009. The percent of
patients reaching the LDL-C treatment goal of less than
100 mg/dL also increased from 83% to 89% (p = .047)
over the course of the program. During the study pe-
riod, we modified the LDL-C goal for the ACS patients to
Table 3 Medication, lipids, and biomarkers
Initial 12 Weeks p-Value
Medications
Aspirin 99.1% 97.7% .08
Ace-inhibitor/ARB 66.7% 64.8% .45
Beta-blockers 87.3% 86.4% .62
Statins 93.0% 94.4% .41
Omega 3 fatty acids 12.2% 60.6% <.0001
Lipids
Non-HDL-C (mg/dL) 107.3 ± 2.1 98.8 ± 25.8 .003
HDL-C (mg/dL) 42.8 ± 2.1 44.1 ± 14.4 .30
LDL-C (mg/dL) 80.2 ± 4.2 74.9 ± 20.4 .03
Triglycerides (mg/dL) 137.0 ± 10.6 121.5 ± 66.5 .04
Body habitus
Weight (lbs) 197.9 ± 40.9 194.9 ± 39.1 .49
BMI*> 30 kg/m2 47.9% 43.2% .02
ARB,angiotensin receptorblocker; non-HDL-C,non-high-density lipoprotein
cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density
lipoprotein cholesterol; BMI, body mass index; lbs, pounds.
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<70 mg/dL as recommended in the guidelines. The num-
ber of patients at LDL-C goal of <70 mg/dL increased
by about 20% (baseline 37% vs. 45% at 12 weeks, p =
.04). Fasting blood sugars (FBSs) were tracked only in the
56 diabetics (36% of cohort). The mean FBS at baseline
was 145 ± 53 mg/dL and at 12 weeks 133 ± 62 mg/dL,
p = .12.
Exercise
A total of 200 patients (94%) were referred to cardiac
rehabilitation and 128 (64%) completed the program. One
hundred thirty-three (66%) were referred by the NP and
67 (34%) by a physician prior to the patient entering
the CAD-DM program. Seventy-two (36%) patients de-
clined cardiac rehab. The major reasons included work
schedule (38.8%), distance from program location or de-
sire for a home exercise program (13.8%), and not inter-
ested (9.7%). The NP referred 38 (53%) of patients who
declined cardiac rehabilitation for a 1-h consult, with an
exercise specialist, to provide a personalized home exercise
program and 30 (79%) attended. Patients reporting seden-
tary habits decreased from 55% at initial visit to 15% at
12 weeks, p < .0001. Patients reporting optimal exercising
levels increased by threefold from 17% at baseline to 51%
at 12 weeks, p < .0001.
Cardiovascular symptoms
Cardiovascular symptoms at the initial and 12-week visit
are summarized in Figure 2. Approximately 10% of pa-
tients had classic angina (defining characteristics for is-
chemia) at baseline, which was reduced to 8% at 12 weeks
(p = .25). A significant number of patients had a decrease
in nonanginal chest discomfort (defining characteristics for
nonischemia) at the completion of the program (17% vs.
7%, p = .0002). A similar reduction was found for atyp-
ical chest discomfort (defining characteristics indetermi-
nate for ischemia or nonischemia) (12% vs. 7%, p = .04)
and dyspnea (21%–9%, p < .0001). Further, there was
a twofold increase in patients free of symptoms after 12
weeks (28%–59%, p < .0001) despite no change in medi-
cation.
Quality of life
The self-perceived QoL of patients was assessed at ini-
tial and 12-week visits by the SF-12 questionnaire on a
scale of 0–100 (designed to have national norm mean 50.0
± 10). The average mental component score (adult pop-
ulation mean 52.4) at the initial visit was 50 ± 11 and
increased significantly to 53 ± 9 (p = .002) at 12 weeks
(Figure 3). The average physical component score (adult
mean 50.8) increased from 44 ± 11 to 48 ± 10 (p = .002).
Knowledge and satisfaction
The 22 question knowledge assessment was given at
baseline and study completion. Patients’ knowledge of
coronary artery disease and risk factors increased from an
average score of 72% ± 17% to 78% ± 15% (p < .0001).
Patient satisfaction scores were available from 135 (63%)
patients. Of these, satisfaction was rated high. On a 10-
point scale satisfaction averaged 9.4 ± 1.6, with 96% of
patients rating the program as 8 or greater.
Discussion
We hypothesized that an NP-based CAD-DM program,
provided postdischarge to patients with an ACS or PCI,
would result in improved compliance with evidence-based
therapies for risk factor reduction, improve patients’ phys-
ical and mental health, and result in high satisfaction. Our
results support that the 12-week NP-based CAD-DM pro-
gram is a viable and feasible means to reach these goals. It
was well accepted by physicians and participating patients.
While the CAD-DM program was intended to determine
whether improved care and outcome could be provided at
the same or reduced cost, these cost variables are beyond
the scope of this report.
Patient participation was approved by over 99% of 1200
internal medicine and family practice faculty who are
employees in an academic practice setting. Patients were
highly satisfied with the program and 85% completed the
program having attended at least three sessions includ-
ing week 12. Participants were highly motivated to modify
their behavior relative to diet, exercise, and stress manage-
ment based on self-reported readiness to change, which
are reflected in the results.
Improvement was found in the self-perception of phys-
ical and mental health as measured by the SF-12. Each
of these is likely related to the decrease in cardiovascular
and noncardiac symptoms and improved fitness facilitated
by cardiac rehab and exercise consultations. It is reason-
able to speculate that the high degree of compliance with
lifestyle change and decrease in symptoms would result in
improved outcomes and less use of healthcare resources.
Telephone calls to the NP during work hours were infre-
quent but the opportunity may have helped relieve anx-
iety. Whether the improved knowledge, confidence, and
decrease in noncardiac chest symptoms will result in fewer
emergency room visits and/or hospitalizations will need to
be assessed.
Blood pressure, lipid parameters, exercise frequency,
and BMI status were all positively affected, including the
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Figure 2 Cardiovascular symptoms expressed by participants at baseline and 12 weeks.
Figure 3 SF-12 Questionnaire: Mental and Physical Assessments. SPF-12 mental and physical component scores at baseline and 12 weeks.
percent of hypertensive patients achieving blood pressure
goal and on-target lipid values. Considering the minimal
changes in medication regimens, the improvement in risk
factors appears to be related to improved lifestyle and
medication compliance. Patients reported increased com-
pliance with statin therapy, implementation of a low fat,
low cholesterol diet, and increase in exercise. Low HDL-C
is predictive of future coronary artery disease events
in patients with prior ACS and at the time of this
study was recommended as a target for treatment
(Davidson & Rosenson, 2009). HDL-C trended upwards
but not significantly. Niacin was recommended to one
third of the patients, but most often was refused or
stopped because of side effects. Cardiac rehabilitation
following an ACS and PCI reduces the risk of future
events and mortality and is strongly recommended by
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guidelines (Hammill, Curtis, Schulman, & Whellan, 2010;
Motivala et al., 2011). Yet the rate of cardiac rehab re-
ferral is only about 20% and there is a significant 50%
drop-off (10%–12% participate) from referral to enroll-
ment (Boyden, Rubenfire, & Franklin, 2010). Similarly,
of the 133 patients referred to cardiac rehab by the NP,
only 71 (53%) completed the program. Sixty-two (47%)
patients dropped out for various reasons, the majority be-
cause of work schedules or distance from the rehab cen-
ter. Thirty-eight (52%) of the dropouts were referred to
an exercise specialist for development of a home program,
of which 30 attended.
The majority of our patients at initial visit were already
taking established AHA/ACC evidence-based secondary
prevention medications in large part because of quality im-
provement activities in our institution (Eagle et al., 2004).
Many studies describe a decline in medication compli-
ance over time, but this was not the case in our study. In
fact, persistence of combined pharmacotherapy regimens
of aspirin, beta-blockers, angiotensin-converting enzyme
inhibitors, angiotensin receptor blockers, and statins re-
mained through the completion of the program. There was
a significant increase in use of omega 3 fatty acids (12.2%
vs. 60.6%). Given that this supplement was not typically
prescribed at hospital discharge, this was an expected find-
ing. Finally, the adherence with evidence-based drugs in
our program is similar to other NP-based care program
and thought to be related to the vigilance in education,
monitoring for adverse effects, modifying doses as needed,
and stressing of the value of medication compliance
(McPherson, Swenson, Pine, & Leimer, 2002; Raftery,
Guiqing, Murchie, Campbell, & Ritchie, 2005; Vale et al.,
2003).
Limitations
There are several limitations to this report. We recog-
nize that the population served is fairly specific (white
males, well educated, who have a job, with an income
less than $75,000 per year), which limits generalizabil-
ity. The physician acceptance and improvement found in
each of the metrics evaluated may not be generalizable in
nonacademic or private practice settings. We have no abil-
ity to assess the degree to which participation and bene-
fits can be attributed to program sponsorship by the em-
ployer and/or insurance carrier. While the program was
well received, less than 50% participated, which may im-
prove with a more timely entry rather than median 30
days from discharge. Barriers to timely patient entry into
the program included delayed hospital discharge reporting
to our research assistant, delayed approval by the primary
care physician, and delayed patient response to the initial
phone call to determine interest. Lastly, we recognize that
those who chose to participate in the CAD-DM program
may be a more motivated group and may not be represen-
tative of the entire post-ACS population.
Conclusion
The NP-based model for coronary care and coronary risk
factor modification in stable coronary disease has been
shown to be effective and cost effective compared to the
medical model (McPherson et al., 2002; Murchie, Camp-
bell, Ritchie, Simpson, & Thain, 2003; Raftery et al., 2005;
Vale et al., 2003). Our results extend those observations
to the postdischarge ACS and PCI patients. This project
demonstrated marked reduction in symptoms and accep-
tance of lifestyle change and medication compliance. Pa-
tient and physicians were highly satisfied with the care and
the outcomes. The care was patient centered and achieved
a high level of guideline-based goals for secondary preven-
tion.
The NP disease management model postdischarge pro-
vides much-needed transitional care and is a complimen-
tary approach to the medical model. Among the unique
characteristics of the cardiovascular NP practice pattern in-
cludes longer time allotment for listening to patient and
significant others concerns, improved availability to pa-
tients and family members, emphasis on education, and
liberal referral to supportive services.
Based upon the evidence of secondary prevention pro-
gram results in stable coronary artery disease, it is likely
that postdischarge CAD-DM programs will lead to im-
proved outcomes and less use of healthcare resources
(Clark et al., 2005; Delaney, Murchi, Lee, Ritchie, &
Campbell, 2007; Ma et al., 2009; McPherson et al., 2002;
Murchie et al., 2003; Raftery et al., 2005; Vale et al.,
2003). The true measure of benefit of the postdischarge
ACS and PCI programwill require a randomized controlled
trial comparing NP disease management to conventional
care.
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